Activation of inflammasomes in adipose tissue of women with gestational diabetes

Molecular and Cellular Endocrinology

Volumn 382, Issue 1, 2014, Pages 74-83

  Lappas, Martha ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MERCY HOSPITAL FOR WOMEN   (Australia)

Author keywords

Adipose tissue; GDM; IL 1 ; Inflammasome; Inflammation; Insulin signalling

Indexed keywords

ADENOSINE TRIPHOSPHATE; GLUCOSE TRANSPORTER 4; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INSULIN RECEPTOR SUBSTRATE 1; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; PURINERGIC P2X7 RECEPTOR;

ADIPOSE TISSUE; ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVATION; FEMALE; GESTATIONAL AGE; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERINSULINEMIA; INSULIN RESISTANCE; ORAL GLUCOSE TOLERANCE TEST; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SIGNAL TRANSDUCTION;

ADIPOSE TISSUE; GDM; IL-1Β; INFLAMMASOME; INFLAMMATION; INSULIN SIGNALLING;

ADENOSINE TRIPHOSPHATE; ADIPOSE TISSUE; ADULT; CASPASE 1; DIABETES, GESTATIONAL; ENZYME ACTIVATION; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INFLAMMASOMES; INSULIN; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; PALMITATES; PREGNANCY; RECEPTORS, PURINERGIC P2X7; SERUM ALBUMIN, BOVINE; SIGNAL TRANSDUCTION;

EID: 84884684232     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2013.09.011     Document Type: Article

References (49)

1. Ajuwon K.M., Spurlock M.E. Palmitate activates the NF-kappa B transcription factor and induces IL-6 and TNF alpha expression in 3T3-L1 adipocytes. J Nutr. 2005, 135:1841-1846.
2. Arend W.P., Palmer G., Gabay C. IL-1, IL-18, and IL-33 families of cytokines. Immunol. Rev. 2008, 223:20-38.
3. Barker G., Lim R., Georgiou H.M., Lappas M. Omentin-1 is decreased in maternal plasma, placenta and adipose tissue of women with pre-existing obesity. PLoS One 2012, 7:e42943.
4. Bauernfeind F., Ablasser A., Bartok E., Kim S., Schmid-Burgk J., Cavlar T., Hornung V. Inflammasomes: current understanding and open questions. Cell. Mol. Life Sci. 2011, 68:765-783.
5. Boni-Schnetzler M., Thorne J., Parnaud G., Marselli L., Ehses J.A., Kerr-Conte J., Pattou F., Halban P.A., Weir G.C., Donath M.Y. Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta -cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation. J. Clin. Endocrinol. Metab. 2008, 93:4065-4074.
6. Buchanan T.A., Xiang A.H. Gestational diabetes mellitus. J. Clin. Invest. 2005, 115:485-491.
7. Catalano P.M., Nizielski S.E., Shao J.H., Preston L., Qiao L.P., Friedman J.E. Downregulated IRS-1 and PPAR gamma in obese women with gestational diabetes: relationship to FFA during pregnancy. Am. J. Physiol. Endocrinol. Metab. 2002, 282:E522-E533.
8. Cavelti-Weder C., Babians-Brunner A., Keller C., Stahel M.A., Kurz-Levin M., Zayed H., Solinger A.M., Mandrup-Poulsen T., Dinarello C.A., Donath M.Y. Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes. Diabetes Care 2012, 35:1654-1662.
9. Colomiere M., Permezel M., Lappas M. Diabetes and obesity during pregnancy alter insulin signalling and glucose transporter expression in maternal skeletal muscle and subcutaneous adipose tissue. J. Mol. Endocrinol. 2010, 44:213-223.
10. Creely S.J., McTernan P.G., Kusminski C.M., Fisher F.M., Da Silva N.F., Khanolkar M., Evans M., Harte A.L., Kumar S. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 2007, 292:E740-E747.
11. Dabelea D., Hanson R.L., Lindsay R.S., Pettitt D.J., Imperatore G., Gabir M.M., Roumain J., Bennett P.H., Knowler W.C. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. Diabetes 2000, 49:2208-2211.
12. Ferrara A. Increasing prevalence of gestational diabetes mellitus: a public health perspective. Diabetes Care 2007, 30(Suppl. 2):S141-S146.
13. Franchi L., Kanneganti T.D., Dubyak G.R., Nunez G. Differential requirement of P2X7 receptor and intracellular K+ for caspase-1 activation induced by intracellular and extracellular bacteria. J. Biol. Chem. 2007, 282:18810-18818.
14. Garvey W.T., Maianu L., Zhu J.H., Hancock J.A., Golichowski A.M. Multiple defects in the adipocyte glucose transport system cause cellular insulin resistance in gestational diabetes. Heterogeneity in the number and a novel abnormality in subcellular localization of GLUT4 glucose transporters. Diabetes 1993, 42:1773-1785.
15. Goossens G.H., Blaak E.E., Theunissen R., Duijvestijn A.M., Clement K., Tervaert J.W., Thewissen M.M. Expression of NLRP3 inflammasome and T cell population markers in adipose tissue are associated with insulin resistance and impaired glucose metabolism in humans. Mol. Immunol. 2012, 50:142-149.
16. Handa M., Vanegas S., Maddux B.A., Mendoza N., Zhu S., Goldfine I.D., Mirza A.M. XOMA 052, an anti-IL-1beta monoclonal antibody, prevents IL-1beta-mediated insulin resistance in 3T3-L1 adipocytes. Obesity (Silver Spring) 2013, 21:306-309.
17. Hornung V., Ablasser A., Charrel-Dennis M., Bauernfeind F., Horvath G., Caffrey D.R., Latz E., Fitzgerald K.A. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 2009, 458:514-518.
18. Jager J., Gremeaux T., Cormont M., Le Marchand-Brustel Y., Tanti J.F. Interleukin-1 beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. Endocrinology 2007, 148:241-251.
19. Kahlenberg J.M., Lundberg K.C., Kertesy S.B., Qu Y., Dubyak G.R. Potentiation of caspase-1 activation by the P2X7 receptor is dependent on TLR signals and requires NF-kappa B-driven protein synthesis. J. Immunol. 2005, 175:7611-7622.
20. Kahn S.E., Hull R.L., Utzschneider K.M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006, 444:840-846.
21. Kim C., Berger D.K., Chamany S. Recurrence of gestational diabetes mellitus: a systematic review. Diabetes Care 2007, 30:1314-1319.
22. Koenen T.B., Stienstra R., van Tits L.J., de Graaf J., Stalenhoef A.F., Joosten L.A., Tack C.J., Netea M.G. Hyperglycemia activates caspase-1 and TXNIP-mediated IL-1beta transcription in human adipose tissue. Diabetes 2011, 60:517-524.
23. Lain K.Y., Catalano P.M. Metabolic changes in pregnancy. Clin. Obstet. Gynecol. 2007, 50:938-948.
24. Lamkanfi M., Dixit V.M. Inflammasomes and their roles in health and disease. Annu. Rev. Cell Dev. Biol. 2012, 28:137-161.
25. Lappas M., Permezel M., Rice G.E. Release of proinflammatory cytokines and 8-isoprostane from placenta, adipose tissue, and skeletal muscle from normal pregnant women and women with gestational diabetes mellitus. J. Clin. Endocrinol. Metab. 2004, 89:5627-5633.
26. Lappas M., Yee K., Permezel M., Rice G.E. Sulfasalazine and BAY 11-7082 interfere with the nuclear factor-kappa B and I kappa B kinase pathway to regulate the release of proinflammatory cytokines from human adipose tissue and skeletal muscle in vitro. Endocrinology 2005, 146:1491-1497.
27. Lappas M., Permezel M., Rice G.E. Leptin and adiponectin stimulate the release of proinflammatory cytokines and prostaglandins from human placenta and maternal adipose tissue via nuclear factor-kappaB, peroxisomal proliferator-activated receptor-gamma and extracellularly regulated kinase 1/2. Endocrinology 2005, 146:3334-3342.
28. Lappas M., Yee K., Permezel M., Rice G.E. Release and regulation of leptin, resistin and adiponectin from human placenta, fetal membranes, and maternal adipose tissue and skeletal muscle from normal and gestational diabetes mellitus-complicated pregnancies. J. Endocrinol. 2005, 186:457-465.
29. Lappas M., Permezel M., Rice G.E. Advanced glycation endproducts mediate pro-inflammatory actions in human gestational tissues via nuclear factor-kappaB and extracellular signal-regulated kinase 1/2. J. Endocrinol. 2007, 193:269-277.
30. Lappas M., Mitton A., Permezel M. In response to oxidative stress, the expression of inflammatory cytokines and antioxidant enzymes are impaired in placenta, but not adipose tissue, of women with gestational diabetes. J. Endocrinol. 2010, 204:75-84.
31. Lappas M., Hiden U., Desoye G., Froehlich J., Hauguel-de Mouzon S., Jawerbaum A. The role of oxidative stress in the pathophysiology of gestational diabetes mellitus. Antioxid. Redox Signal. 2011, 15:3061-3100.
32. Lappas M., Andrikopoulos S., Permezel M. Hypoxanthine-xanthine oxidase down-regulates GLUT1 transcription via SIRT1 resulting in decreased glucose uptake in human placenta. J. Endocrinol. 2012, 213:49-57.
33. Larsen C.M., Faulenbach M., Vaag A., Volund A., Ehses J.A., Seifert B., Mandrup-Poulsen T., Donath M.Y. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N. Engl. J. Med. 2007, 356:1517-1526.
34. Maelfait J., Vercammen E., Janssens S., Schotte P., Haegman M., Magez S., Beyaert R. Stimulation of Toll-like receptor 3 and 4 induces interleukin-1beta maturation by caspase-8. J. Exp. Med. 2008, 205:1967-1973.
35. Mandrup-Poulsen T., Pickersgill L., Donath M.Y. Blockade of interleukin 1 in type 1 diabetes mellitus. Nat. Rev. Endocrinol. 2010, 6:158-166.
36. Mohr S., Xi X., Tang J., Kern T.S. Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients. Diabetes 2002, 51:1172-1179.
37. Pelegrin P., Barroso-Gutierrez C., Surprenant A. P2X(7) receptor differentially couples to distinct release pathways for IL-1 beta in mouse macrophage. J. Immunol. 2008, 180:7147-7157.
38. Radaelli T., Uvena-Celebrezze J., Minium J., Huston-Presley L., Catalano P., Hauguel-de Mouzon S. Maternal interleukin-6: marker of fetal growth and adiposity. J. Soc. Gynecol. Invest. 2006, 13:53-57.
39. Schroder K., Tschopp J. The Inflammasomes. Cell 2010, 140:821-832.
40. Sobngwi E., Boudou P., Mauvais-Jarvis F., Leblanc H., Velho G., Vexiau P., Porcher R., Hadjadj S., Pratley R., Tataranni P.A., Calvo F., Gautier J.F. Effect of a diabetic environment in utero on predisposition to type 2 diabetes. Lancet 2003, 361:1861-1865.
41. Solle M., Labasi J., Perregaux D.G., Stam E., Petrushova N., Koller B.H., Griffiths R.J., Gabel C.A. Altered cytokine production in mice lacking P2X(7) receptors. J. Biol. Chem. 2001, 276:125-132.
42. Spranger J., Kroke A., Mohlig M., Hoffmann K., Bergmann M.M., Ristow M., Boeing H., Pfeiffer A.F. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European prospective investigation into cancer and nutrition (EPIC)-potsdam study. Diabetes 2003, 52:812-817.
43. Stienstra R., Joosten L.A., Koenen T., van Tits B., van Diepen J.A., van den Berg S.A., Rensen P.C., Voshol P.J., Fantuzzi G., Hijmans A., Kersten S., Muller M., van den Berg W.B., van Rooijen N., Wabitsch M., Kullberg B.J., van der Meer J.W., Kanneganti T., Tack C.J., Netea M.G. The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. Cell Metab. 2010, 12:593-605.
44. Tack C.J., Stienstra R., Joosten L.A.B., Netea M.G. Inflammation links excess fat to insulin resistance: the role of the interleukin-1 family. Immunol. Rev. 2012, 249:239-252.
45. Vandanmagsar B., Youm Y.H., Ravussin A., Galgani J.E., Stadler K., Mynatt R.L., Ravussin E., Stephens J.M., Dixit V.D. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med. 2011, 17:U179-U214.
46. Wang C., Pan Y., Zhang Q.Y., Wang F.M., Kong L.D. Quercetin and allopurinol ameliorate kidney injury in STZ-treated rats with regulation of renal NLRP3 inflammasome activation and lipid accumulation. PLoS One 2012, 7.
47. Winzer C., Wagner O., Festa A., Schneider B., Roden M., Bancher-Todesca D., Pacini G., Funahashi T., Kautzky-Willer A. Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus. Diabetes Care 2004, 27:1721-1727.
48. Wolf M., Sauk J., Shah A., Smirnakis K.V., Jimenez-Kimble R., Ecker J.L., Thadhani R. Inflammation and glucose intolerance - A prospective study of gestational diabetes mellitus. Diabetes Care 2004, 27:21-27.
49. Xu H.Y., Barnes G.T., Yang Q., Tan Q., Yang D.S., Chou C.J., Sole J., Nichols A., Ross J.S., Tartaglia L.A., Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 2003, 112:1821-1830.